ReShape Lifesciences Inc. (NASDAQ: RSLS)
$4.6600
-0.0600 ( +3.10% ) 4.5K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$4.6600
Previous close
$4.7200
Volume
4.5K
Market cap
$3.23M
Day range
$4.5100 - $4.7390
52 week range
$4.0900 - $29.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 21 | Jul 09, 2024 |
| 8-k | 8K-related | 16 | May 20, 2024 |
| 10-q | Quarterly Reports | 60 | May 15, 2024 |
| 8-k | 8K-related | 13 | Apr 10, 2024 |
| 8-k | 8K-related | 15 | Apr 10, 2024 |
| 8-k | 8K-related | 15 | Apr 04, 2024 |
| 10-k | Annual reports | 88 | Apr 01, 2024 |
| 8-k | 8K-related | 14 | Feb 26, 2024 |
| def | Proxies and info statements | 6 | Jan 24, 2024 |
| 8-k | 8K-related | 13 | Jan 18, 2024 |